mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model
AbstractThe mechanistic target of rapamycin (mTOR), a serine-threonine kinase, plays a pivotal role in regulating cell growth and proliferation. Notably, a great deal of evidence indicates that mTOR signaling is also crucial in controlling proliferation and differentiation of several stem cell compartments. Consequently, dysregulation of the mTOR pathway is often associated with a variety of disease, such as cancer and metabolic and genetic disorders. For instance, hyperactivation of mTORC1 in neural stem cells (NSCs) is associated with the insurgence of neurological manifestation characterizing tuberous sclerosis complex (TSC). In this review, we survey the recent contributions of TSC physiopathology studies to understand the role of mTOR signaling in both neurogenesis and tumorigenesis and discuss how these new insights can contribute to developing new therapeutic strategies for neurological diseases and cancer. View Full-Text
Share & Cite This Article
Polchi, A.; Magini, A.; Meo, D.D.; Tancini, B.; Emiliani, C. mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model. Int. J. Mol. Sci. 2018, 19, 1474.
Polchi A, Magini A, Meo DD, Tancini B, Emiliani C. mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model. International Journal of Molecular Sciences. 2018; 19(5):1474.Chicago/Turabian Style
Polchi, Alice; Magini, Alessandro; Meo, Danila D.; Tancini, Brunella; Emiliani, Carla. 2018. "mTOR Signaling and Neural Stem Cells: The Tuberous Sclerosis Complex Model." Int. J. Mol. Sci. 19, no. 5: 1474.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.